TrialAdvances in therapy2022

Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial.

Michael Dreher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.